Alessandra Castrogiovanni

TL;DR: A narrative review of recent studies on OSA patients, with special attention to cardiovascular and cerebrovascular comorbidities, the metabolic syndrome and type 2 diabetes, asthma, COPD and cancer, to provide an update on recent studies.

TL;DR: The visceral adiposity index was a good marker of metabolic syndrome, but not of obstructive sleep apnea, and changed little in patients without metabolic syndrome; conversely, waist circumference was the only correlate of apnea–hypopnea index in men and women with metabolic syndrome.

TL;DR: This review summarises the available studies on the physiological phenotypes of upper airway response to obstruction during sleep, and the clinical presentations of OSA (phenotypes and clusters) with a special focus on changing attitudes towards approaches to treatment.

TL;DR: The present report evaluates the epidemiology of MVA in patients with OSA; the mechanisms involved in this association; the role of screening questionnaires, driving simulators and other techniques to evaluate sleepiness and/or impaired vigilance; the impact of treatment on MVA risk in affected drivers; and highlights the evidence gaps regarding the identification of OSA patients at risk of M VA.

TL;DR: As CVD patients show a high SDB prevalence and poor outcome, only a systematic screening based on measures of respiration-related parameters allows for a reliable SDB assessment.